SetPoint Medical

Santa Clarita, United States Founded: 2006 • Age: 20 yrs
Implantable neuromodulation devices are developed for inflammatory diseases.

About SetPoint Medical

SetPoint Medical is a Healthcare company based in Santa Clarita (United States) founded in 2006. Implantable neuromodulation devices are developed for inflammatory diseases. SetPoint Medical has raised $363.17 million across 13 funding rounds from investors including Medtronic, Boston Scientific and Norwest Venture Partners. The company has 46 employees. SetPoint Medical offers products and services including Neuroimmune Modulation Device and RESET-RA Study Platform. Its focus areas include Life Sciences, Immunology, Medical Devices and Orthopedics. Its legal entity is SETPOINT MEDICAL CORPORATION. Its competitors include Harmonic Bionics, Boomerang Medical and CyMedica Ortho; 3 of its 3 listed competitors have raised funding.

Company details

SetPoint Medical was founded in 2006 and is based in Santa Clarita, United States. Focus is placed on the development of implantable neuromodulation devices targeted at inflammatory conditions, including Crohns Disease and rheumatoid arthritis. Operations center on advancing bioelectronic medicine within the medical device sector. Clinical trials for Crohns Disease are presently being conducted, with emphasis on therapeutic applications for autoimmune disorders.

  • Headquarters Santa Clarita, United States
  • Employees 46
  • Sectors
    Healthcare
  • Website setpointmedical.com
  • Social LinkedIn X
  • Legal Name Setpoint Medical Corporation
Key Metrics
  • Total Equity Funding
    $363.17M (USD)

    in 13 rounds

  • Latest Funding Round
    $115M (USD), Series F

    Mar 2025

  • Investors
    Medtronic

    & 25 more

  • Employee Count
    46

Products & Services of SetPoint Medical

SetPoint Medical offers a comprehensive portfolio of products and services, including Neuroimmune Modulation Device and RESET-RA Study Platform.

Neuroimmune Modulation Device
Medical Device

Electrical stimulation platform to regulate inflammation in autoimmune diseases

RESET-RA Study Platform
Clinical Research Tool

System for testing neuroimmune treatments in rheumatoid arthritis patients

Funding Insights of SetPoint Medical

SetPoint Medical has successfully raised a total of $363.17M across 13 strategic funding rounds. The most recent funding activity was a Series F round of $115 million completed in March 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $363.17M
  • Total Rounds 13
  • Last Round Series F β€” $115M
  • First Round $4M

    (May 2009)

  • Investors Count 26

Latest 10 of 13 funding rounds of SetPoint Medical with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Mar 2025$115MSeries F––
–
Jan 2023$80MSeries E–Norwest Venture Partners, Viking Global Investors
Jan 2023Debt – Conventional––
Jul 2021$35MDebt – Conventional––
Jan 2021$64.41MSeries E–New Enterprise Associates
Sep 2019$15.75MSeries D––
–
Aug 2017$30MSeries D––
Mar 2017Series C––
Sep 2015$15.11MSeries C––
Aug 2013$30.61MSeries B–Medtronic, GSK
–
Valuation history

26 investors in total: 26 institutional.

Investors in SetPoint Medical

SetPoint Medical has secured backing from 26 investors, including venture fund and institutional investors. Prominent investors backing the company include Medtronic, Boston Scientific and Norwest Venture Partners.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Venture capital and growth equity firm providing investments and resources to entrepreneurs in various sectors.
1961nvp.comMenlo Park, United States
Private investment firm focused on multiple sectors
vikingglobal.comGreenwich, United States
Venture capital investments are offered to startups by NEA.
nea.comMenlo Park, United States
Stage-agnostic investments in US life sciences are pursued.
actionpotentialvc.comPalo Alto, United States
Venture capital and private equity investment firm
morgenthaler.comPortola Valley, United States
shangbaycapital.com
Venture capital is provided to biomedical technology startups.
cataliocapital.comNew York, United States
cittacapital.com
Early-stage life science ventures are supported by SVE Capital.
2020sve-capital.comPalo Alto, United States
Topspin Consumer Partners is engaged in private equity investments focused on consumer brands.
topspincp.comMamaroneck, USA
Premium access

Investor details for SetPoint Medical

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of SetPoint Medical

40 people are tracked at SetPoint Medical (15 in leadership, 6 in board & advisors, 19 in team); the tracked headcount is 46.

NameRoleGroup
Dan Ward
Director, Program ManagementLeadership
Melissa Evangelista
Director, Clinical AffairsLeadership
Yaakov Levine
VP of ResearchLeadership
John Long
VP, OperationsLeadership
Ankit Shah
VP of MarketingLeadership
David Chernoff
Chief Medical OfficerLeadership
Kevin Wilkin
VP of QualityLeadership
Bill Calle
VP, Product DevelopmentLeadership
Amy Derosier
VP, Clinical AffairsLeadership
Murthy Simhambhatla
CEOLeadership
Nichole Greetis
Director, Quality AssuranceLeadership
Ashley Waterstone
Director Of Marketing And Clinical ExcellenceLeadership
Rohan Seth
CFOLeadership
Lauren Dibiase Corso
Associate Director, Clinical OperationsLeadership
Erik Styacich
Vice President Of SalesLeadership
Steve Winick
DirectorBoard & advisors
William Dai
DirectorBoard & advisors
Allan Will
ChairmanBoard & advisors
Josh Makower
DirectorBoard & advisors
Hank Plain
DirectorBoard & advisors

20 more people are available in the full profile.

Premium access

Complete people profiles for SetPoint Medical

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of SetPoint Medical

3 dated milestones of SetPoint Medical across 19 years, from founding to its latest funding, stage changes and deals.

  1. Founded SetPoint Medical is founded.
  2. Funding First funding round of $4.0M.
  3. Funding Latest funding round, Series F, of $115.0M.

Competitors of SetPoint Medical

SetPoint Medical has 3 listed competitors in our database, 3 of them funded. They include Harmonic Bionics, Boomerang Medical and CyMedica Ortho.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
harmonicbionics.com2016Austin, United States$12.92M
Robotic solutions for upper body rehabilitation are provided.
boomerangmedical.com2021Mountain View, United States$35M
Bioelectronic devices are developed for autoimmune disease treatment.
cymedicaortho.com2013Phoenix, United States$32.83M14
Neuromuscular electrical stimulation platform to prevent Muscle atrophy after orthopedic surgeries
Premium access

Detailed competitors of SetPoint Medical

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of SetPoint Medical

The website of SetPoint Medical (setpointmedical.com) receives about 9.4K visits a month.

  • Monthly visits
    9.4K

    ▼ 4.6% vs previous month

Similar websites

Websites whose visitors overlap most with SetPoint Medical. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
testsource.com
100%
View details
rheumatologyadvisor.com
rheumatologyadvisor.com
92%
#417,216–
massdevice.com
91%
#435,992View details
bostonscientific.com
91%
738.5K#88,615View details
pharmacyonesource.com
64%
149.4K#184,263View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 7 similar websites and full traffic analytics for SetPoint Medical

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 7 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Immunology & Cancer Therapeutics

3 companies that operate in the same segment as SetPoint Medical (Immunology & Cancer Therapeutics) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
mRNA-based therapeutics for diseases including cancer and infections are developed.
2010Cambridge, Massachusetts, United StatesUSD 2.78 BUSD 1.94 B5,800
Targeted and immune-oncology drugs for cancer treatment are developed.
2010Cambridge, Massachusetts, United StatesUSD 172 M
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed.
2013San Francisco, California, United StatesUSD 214.78 MUSD 21.05 M211
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Setpoint Medical

Premium access

Complete news archive for SetPoint Medical

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about SetPoint Medical

SetPoint Medical was founded in 2006 and raised its 1st funding round 3 years after it was founded.

SetPoint Medical is headquartered in Santa Clarita, United States. It is registered at Santa Clarita, California, United States.

SetPoint Medical is a funded company, having raised a total of $363.17M across 13 funding rounds to date. The company's 1st funding round was a Series B of $30.61M, raised on May 2009.

SetPoint Medical has 46 employees.

SetPoint Medical was founded in 2006 and is based in Santa Clarita, United States. Focus is placed on the development of implantable neuromodulation devices targeted at inflammatory conditions, including Crohns Disease and rheumatoid arthritis. Operations center on advancing bioelectronic medicine within the medical device sector. Clinical trials for Crohns Disease are presently being conducted, with emphasis on therapeutic applications for autoimmune disorders.

SetPoint Medical's top competitors include Harmonic Bionics, Boomerang Medical and CyMedica Ortho.

SetPoint Medical offers Neuroimmune Modulation Device and RESET-RA Study Platform.

SetPoint Medical has 26 investors. Key investors include Medtronic, Boston Scientific, Norwest Venture Partners, GSK, and Revelation Partners.

SetPoint Medical operates through Setpoint Medical Corporation.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available